Breast Cancer Awareness Month Raises Questions About Antipsychotic Drug Warnings

RisperdalInvegaZyprexaNegative

AI Analysis

Summary

Wisner Baum filed lawsuits against manufacturers of Risperdal, Invega, and Zyprexa alleging inadequate warnings about breast cancer risks linked to prolactin-elevating antipsychotics. The litigation claims manufacturers failed to properly warn patients and physicians about the safety concern.

Outcome Details

Litigation alleging failure to warn about breast cancer risks

Importance:6/10

Sentiment:

-0.80

LitigationProduct LiabilityAntipsychoticBreast Cancer RiskWarning LabelsProlactin

Related Companies

$LLY

Read the original article

Published by PR Newswire Pharma on October 7, 2026 3:46 PM

Read Original